SCHEMBL6176337

SCHEMBL6176337

COc1ccc(C(=O)Nc2cc(C(C)C3NC(=O)N(c4ccc(S(=O)(=O)C(F)(F)F)cc4)C3=O)ccn2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.39
RAB9A P51151 6/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 1/20 0.38
MITF O75030 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
XBP1 P17861 1/20 0.38
HTT P42858 1/20 0.38
F2 P00734 1/20 0.38
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RPS6KA2 Q15349 1/20 0.36
MAPK13 O15264 1/20 0.35
MAPK12 P53778 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174110 0.92 NPC1 (0.39) NPC1RAB9AALDH1A1MAPK14CBLB
SCHEMBL6172184 0.92 NPC1 (0.39) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL6173765 0.87 KCNK2 (0.44) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL6175133 0.86 GRM5 (0.43) NPC1RAB9AALDH1A1TP53MAPT
SCHEMBL6173893 0.84 LMNA (0.39) MEN1KMT2AALDH1A1TP53GAA
SCHEMBL6175377 0.84 IGF1R (0.35) ALDH1A1MAPTGAAMAPK14CBLB
SCHEMBL6174034 0.83 CBLB (0.36) NPC1RAB9AALDH1A1KDM4ETP53
SCHEMBL6173224 0.83 LMNA (0.36) KMT2AALDH1A1KDM4ETP53MAPT
SCHEMBL6174217 0.83 IGF1R (0.38) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL6174274 0.83 GCGR (0.42) NPC1RAB9AMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed